A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
A long-term safety study of ferric citrate (KRX-0502) in renal failure patients who have
completed study KRX-0502-304. Only patients who participated in the KRX-0502-304 trial may
participate in this trial.